Virological Control during the First 6–18 Months after Initiating Highly Active Antiretroviral Therapy as a Predictor for Outcome in HIV-Infected Patients: A Danish, Population-Based, 6-Year Follow-Up Study

This publication has 28 references indexed in Scilit:

• Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study
  Scandinavian Journal of Infectious Diseases, 2005
• Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection
  New England Journal of Medicine, 2004
• Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine
  AIDS, 2003
• Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
  AIDS, 2003
• Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
  Annals of Internal Medicine, 2002
• Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients
  AIDS, 2002
• Association of Virus Load, CD4 Cell Count, and Treatment with Clinical Progression in Human Immunodeficiency Virus–Infected Patients with Very Low CD4 Cell Counts
  The Journal of Infectious Diseases, 2002
• A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study
  The Journal of Infectious Diseases, 2002
• Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population
  AIDS, 2000
• Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
  AIDS, 1999